Melissa Loi is a member of the Cancer Genetics and Functional Genomics Research group in the Centre for Cancer Research.

Learn more about my group's research

Melissa Loi from the Cancer Genetics and Functional Genomics Research Group at Hudson Institute

Areas of interest

Bowel cancer Childhood cancer Necrotising enterocolitis (NEC)

Research group

Cancer Genetics and Functional Genomics


Melissa Loi is the Technical Sequencing Specialist for the Next Generation Precision Medicine program.

Melissa’s role involves using molecular methods to assist in generating an encyclopaedia of genomic profiles for childhood brain tumours.  Her main project focuses on preparing samples with biomechanical techniques for next generation sequencing in order to analyse and discern gene regulatory elements.

Utilising established in vitro models of brain cancer, Melissa aims to assist in decoding the epigenetics modifications that regulate gene expression, underlying disease, in order to further understand brain tumourigenesis in the paediatric population.

Melissa completed her Bachelor in Biotechnology and Honours in Nanotechnology from the University of South Australia. Prior to joining Next Generation Precision Medicine, Melissa was a medical scientist in commercial laboratories, including pathology and quality control.